Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
Clinical trial NCT00733551 · COMPLETED
Trial details
- NCT number
- NCT00733551
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-23
- Primary completion
- 2009-07-20
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.